Generic, Branded Generic & Proprietary Medicinal Products - Group 18
A Contract Award Notice
by REGIONAL BUSINESS SERVICES ORGANISATION, PROCUREMENT AND LOGISTICS SERVICE
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 10 year (est.)
- Value
- £11M
- Sector
- HEALTH
- Published
- 03 Jul 2026
- Delivery
- To 02 Jul 2036 (est.)
- Deadline
- n/a
Related Terms
Location
Belfast
2 buyers
40 suppliers
- Abbvie Maidenhead
- Accord Barnstaple
- Amarox Harrow
- Aspire Pharma Petersfield
- Aventis Pharma Reading
- B Braun Medical Sheffield
- Baxter Healthcare Thetford
- Bayer Reading
- Bowmed Ibisqus Wrexham
- Chiesi Cheadle
- Colonis Pharma London
- Drugsruus Northwood
- Esteve Pharmaceuticals Maidenhead
- Focus Pharmaceuticals London
- Fresenius Kabi Runcorn
- Glenmark Pharmaceuticals Europe Watford
- Glaxosmithkline Brentford
- Hamlen Pharma Gloucester
- Lupin Healthcare Slough
- Macarthys Laboratories Romford
- Medac Pharma London
- Merck Sharp & Dohme London
- Mercury Pharmaceuticals LT London
- Morningside Pharmaceuticals Loughborough
- Novumgen London
- Pfizer Sandwich
- Provepharm London
- Roche Products Welwyn Garden City
- Rosemont Pharmaceuticals Leeds
- Stirling Anglian Pharmaceuticals Glasgow
- Sun Pharma Uxbridge
- Swedish Orphan Biovitrum Cambridge
- Takeda Bucks
- Teva Castleford
- Thornton & Ross Huddersfield
- Tillomed Laboratories Luton
- Torbay Pharmaceuticals Paignton
- Viatris UK Healthcare Potters Bar
- Wockhardt UK Holdings Wrexham
- Zentiva Pharma Guildford
Description
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
Total Quantity or Scope
Eighteenth group tender for Generic, Branded Generic & Proprietary Medicinal Products
Award Detail
| 1 | Abbvie (Maidenhead)
|
| 2 | Accord (Barnstaple)
|
| 3 | Amarox (Harrow)
|
| 4 | Aspire Pharma (Petersfield)
|
| 5 | Aventis Pharma (Reading)
|
| 6 | B Braun Medical (Sheffield)
|
| 7 | Baxter Healthcare (Thetford)
|
| 8 | Bayer (Reading)
|
| 9 | Bowmed Ibisqus (Wrexham)
|
| 10 | Chiesi (Cheadle)
|
| 11 | Colonis Pharma (London)
|
| 12 | Drugsruus (Northwood)
|
| 13 | Esteve Pharmaceuticals (Maidenhead)
|
| 14 | Focus Pharmaceuticals (London)
|
| 15 | Fresenius Kabi (Runcorn)
|
| 16 | Glenmark Pharmaceuticals Europe (Watford)
|
| 17 | Glaxosmithkline (Brentford)
|
| 18 | Hamlen Pharma (Gloucester)
|
| 19 | Lupin Healthcare (Slough)
|
| 20 | Macarthys Laboratories (Romford)
|
| 21 | Medac Pharma (London)
|
| 22 | Merck Sharp & Dohme (London)
|
| 23 | Mercury Pharmaceuticals LT (London)
|
| 24 | Morningside Pharmaceuticals (Loughborough)
|
| 25 | Novumgen (London)
|
| 26 | Pfizer (Sandwich)
|
| 27 | Provepharm (London)
|
| 28 | Roche Products (Welwyn Garden City)
|
| 29 | Rosemont Pharmaceuticals (Leeds)
|
| 30 | Stirling Anglian Pharmaceuticals (Glasgow)
|
| 31 | Sun Pharma (Uxbridge)
|
| 32 | Swedish Orphan Biovitrum (Cambridge)
|
| 33 | Takeda (Bucks)
|
| 34 | Teva (Castleford)
|
| 35 | Thornton & Ross (Huddersfield)
|
| 36 | Tillomed Laboratories (Luton)
|
| 37 | Torbay Pharmaceuticals (Paignton)
|
| 38 | Viatris UK Healthcare (Potters Bar)
|
| 39 | Wockhardt UK Holdings (Wrexham)
|
| 40 | Zentiva Pharma (Guildford)
|
Award Criteria
| Award Criteria (Eligibility Envelope): Compliance with Contract Scope and Specification | _ |
| Award Criteria (Eligibility Envelope): Supply and Delivery of Product (i) (Evidence of Compliance with Good Distribution Practice (GDP) Requirements, as outlined in the Contract Scope and Specification) | _ |
| Award Criteria (Eligibility Envelope): Supply and Delivery of Product (ii) (Evidence of compliance with the Medical Device supply / EU Authorised Representative requirements as outlined in the Contract Scope and Specification) | _ |
| Award Criteria (Eligibility Envelope): Registration on the NHS Evergreen Sustainable Supplier Assessment platform, as outlined in the Contract Scope and Specification) | _ |
| Award Criteria (Technical Envelope): Supply and Delivery of Product (Same Working Day Delivery) | 5.0 |
| Award Criteria (Technical Envelope): Supply and Delivery of Product (Wholesale Distribution) | 5.0 |
| Award Criteria (Technical Envelope): Continuity of Supply (Minimum Committed Stockholding) | 8.0 |
| Award Criteria (Eligibility Envelope): Governance, Quality Control and Risk (Pharmaceutical Quality Assessment (PQA) Section 1) | _ |
| Award Criteria (Technical Envelope): Governance, Quality Control and Risk (Pharmaceutical Quality Assessment (PQA) Section 2 - Section 6) | 40.0 |
| PRICE | 42.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated total value of contract (excluding VAT) is GBP 11,409,969.64 to GBP 64,181,079.24. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts documents and provides for potential growth of up to 50% over the course of the contract. The total value of contract (detailed in section V.2.4)) awarded to each of the contractors indicated in this notice is based on an initial contract period of 24 months. It is important to note that there is available provision to extend this initial contract period in accordance with Section 2 of the SS17bc Commercial Conditions of Contract for Supplies Contracts document
Reference
- FTS 062803-2026